At Seattle BioMed, we’ve chosen an audacious goal: to conduct targeted research leading to new solutions — diagnostics, drugs and vaccines — for global infectious diseases. Why infectious disease? Each year, more than 14 million men, women and children perish from malaria, HIV/AIDS and tuberculosis, as well as lesser-known, but equally deadly diseases such as African sleeping sickness and Chagas’ disease.

These diseases are the leading cause of death globally. The resulting devastation encompasses many other factors as well: children who are left parentless due to the scourge of HIV/AIDS and adults who cannot be productive members of society due to malaria, to name a few. And, estimates show that, by 2020, the cumulative deaths from infectious diseases will be well over 100 million, if these diseases remain unchecked.

But there is hope. Seattle BioMed scientists are working every day to find solutions to the world’s most devastating diseases.

Disease Under Study at Seattle BioMed

• Emerging Infections
  Tuberculosis
  Yeast and mold infections
  Entamoeba histolytica
  Mycobacterium avium complex (MAC)
  Other waterborne diseases
• HIV/AIDS
• Malaria
• Trypanosomatids
  African sleeping sickness
  Chagas’ disease
  Leishmaniasis
• Toxoplasmosis